Is DEXI a Multiple Sclerosis Susceptibility Gene?
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26031175 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anna M Eriksson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway. Hauptthemen laut MEDLINE: Multiple Sclerosis, Genetic Predisposition to Disease, Lectins, C-Type, Monosaccharide Transport Proteins. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Oslo, Norwegian Research Council, Odd Fellow Society.
Abstract (Originalsprache)
The genetic landscape of multiple sclerosis (MS) has been extensively mapped, yielding significant insights into the molecular mechanisms of the disorder. Early studies highlighted key genes associated with the immune system, particularly T cells, as critical for MS susceptibility. Subsequent large-scale genome-wide association studies (GWASs) identified over 200 genetic variants linked to MS, revealing a complex interplay between MS risk and genes involved in various processes within adaptive and innate immune cells, as well as brain-resident microglia. Recently, a groundbreaking GWAS pinpointed the first gene variant associated with MS disease progression, distinguishing the mechanisms driving disease onset from those influencing progression. The C-type lectin domain family 16, member A (CLEC16A) gene within the 16p13 region has consistently been shown to be associated with increased risk of developing both MS and other autoimmune disorders. Notably, several autoimmune-associated genetic variants in CLEC16A introns act as expression quantitative trait loci for the dexamethasone-induced protein (DEXI gene, adding DEXI to the growing list of MS susceptibility genes. This review explores the molecular and functional characterization of DEXI with a particular focus on recent advances in understanding its role in autoimmunity, specifically in the context of multiple sclerosis. We underscore the importance of continued molecular investigation of susceptibility loci for MS identified in genetic studies, with the goal of translating this knowledge into clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway.
- Department of Research, Østfold Hospital, Postboks 300, 1714 Grålum, Norway.
- Department of Research, Innovation and Education, Oslo University Hospital, Kirkeveien 166, 0450 Oslo, Norway.
- Department of Neurology, Oslo University Hospital, Kirkeveien 166, 0450 Oslo, Norway.
- Department of Mechanical, Electronic and Chemical Engineering, Oslo Metropolitan University, Pilestredet 35, 0166 Oslo, Norway.
ORCID-Profile: Hanne F Harbo
Förderung
- University of Oslo
- Norwegian Research Council
- Odd Fellow Society
Zitieren
APA
Eriksson, A. M., Emini, N., Harbo, H. F., & Berge, T. (2025). Is DEXI a Multiple Sclerosis Susceptibility Gene?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031175
Vancouver
Eriksson AM, Emini N, Harbo HF, Berge T. Is DEXI a Multiple Sclerosis Susceptibility Gene?. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031175
BibTeX
@article{Eriksson2025,
author = {Eriksson, Anna M and Emini, Nora and Harbo, Hanne F and Berge, Tone},
title = {Is DEXI a Multiple Sclerosis Susceptibility Gene?},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26031175}
}
EUVIMED